FindTrial
Sign In

Real-World Study of KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets: A Retrospective Cohort Study

Real-World Study of KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055276
Enrollment
Unknown
Registered
2022-01-05
Start date
2022-01-06
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Case series:NA

Sponsors

School of Public Health, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Buy KEYLID's Glucosamine Chondroitin Sulfate Calcium Tablets and take it by themselves; 2. Aged >= 18 years; 3. Participants who have taken Jianli Polysaccharide Chondroitin Calcium Tablets and are willing to participate in the retrospective survey.

Exclusion criteria

Exclusion criteria: People with mental illness are unable to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Subjective Feeling Evaluation Likert Scale;—

Secondary

MeasureTime frame
Simplified Pain Questionnaire;—

Countries

China

Contacts

Public ContactXia Min

Sun Yat-Sen University

xiamin@mail.sysu.edu.cn+86 20 87332433

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026